- Ciechanover A. The ubiquitin-proteasome pathway: On protein death and cell life. EMBO J 1998; 17(24): 7151–7160
Article PubMed Google Scholar
- McNaught KS, Olanow CW, Halliwell B, Isacson O, Jenner P. Failure of the ubiquitin-proteasome system in Parkinson’s disease. Nature Rev Neurosci 2001; 2: 589–594.
Article Google Scholar
- Lang-Rollin I, Rideout HJ, Stefanis L. Ubiquitinated inclusions and neuronal cell death. Histol Histopathol 2003; 18(2): 509–517.
PubMed Google Scholar
- Shimura H, Hattori N, Kubo S, et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 2000; 25(3): 302–305.
Article PubMed Google Scholar
- Leroy E, Boyer R, Auburger G, et al. The ubiquitin pathway in Parkinson’s disease. Nature 1998; 395(6701): 451–452.
Article PubMed Google Scholar
- Tanaka Y, Engelender S, Igarashi S, et al. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum Mol Genet 2001; 10(9): 919–926.
Article PubMed Google Scholar
- Stefanis L, Larsen KL, Rideout HJ, Sulzer DS, Greene LA. Expression of A53T mutant, but not wild type, α-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J Neurosci 2001; 21: 9549–9560.
PubMed Google Scholar
- Petrucelli L, O’Farrell C, Lockhart PJ, et al. Parkin protects against the toxicity associated with mutant alpha-synuclein: Proteasome dysfunction selectively affects catecholaminergic neurons. Neuron 2002; 36(6): 1007–1019.
Article PubMed Google Scholar
- Rideout HJ, Larsen KL, Sulzer D, Stefanis L. Proteasomal inhibition leads to formation of ubiquitin/α-Synuclein-immunoreactive inclusions in PC12 Cells. J Neurochem 2001; 78(4): 899–908.
Article PubMed Google Scholar
- Rideout HJ, Stefanis L. Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination. Mol Cell Neurosci 2002; 21(2): 223–238.
Article PubMed Google Scholar
- Rideout HJ, Wang Q, Park DS, Stefanis L. Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition. J Neurosci 2003; 23(4): 1237–1245.
PubMed Google Scholar
- Dietrich P, Rideout HJ, Wang Q, Stefanis L. Lack of p53 delays apoptosis, but increases ubiquitinated inclusions, in proteasomal inhibitor-treated cultured cortical neurons. Mol Cell Neurosci 2003; 24(2): 430–441.
Article PubMed Google Scholar
- Troy CM, Stefanis L, Prochiantz A, Greene LA, Shelanski ML. The contrasting roles of ICE family proteases and interleukin-1beta in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation. Proc Natl Acad Sci USA 1996; 93(11): 5635–5640.
Article PubMed Google Scholar
- Troy CM, Stefanis L, Greene LA, Shelanski ML. Nedd2 is required for apoptosis after trophic factor withdrawal, but not superoxide dismutase (SOD1) downregulation, in sympathetic neurons and PC12 cells. J Neurosci 1997; 17(6): 1911–1918.
PubMed Google Scholar
- Fenteany G, Schreiber SL. Lactacystin, proteasome function, and cell fate. J Biol Chem 1998; 273(15): 8545–8548.
Article PubMed Google Scholar
- Rideout HJ, Stefanis L. Caspase inhibition: A potential therapeutic strategy in neurological diseases. Histol Histopathol 2001; 16(3): 895–908.
PubMed Google Scholar
- Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 2002; 9(3): 459–470.
Article PubMed Google Scholar
- Bredesen DE. Apoptosis: Overview and signal transduction pathways. J Neurotrauma 2000; 17(10): 801–810.
PubMed Google Scholar
- Stennicke HR, Deveraux QL, Humke EW, Reed JC, Dixit VM, Salvesen GS. Caspase-9 can be activated without proteolytic processing. J Biol Chem 1999; 274(13): 8359–8362.
Article PubMed Google Scholar
- Figueiredo-Pereira M, Berg K, Wilk S. A new inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S Proteasome) induces accumulation of ubiquitin-protein conjugates in a neuronal cell. J Neurochem 1994; 63: 1578–1581.
PubMed Google Scholar
- Stefanis L, Park DS, Yan CY, et al. Induction of CPP32-like activity in PC12 cells by withdrawal of trophic support. Dissociation from apoptosis. J Biol Chem 1996; 271(48): 30663–30671.
Article PubMed Google Scholar
- Stefanis L, Troy CM, Qi H, Shelanski ML, Greene LA. Caspase-2 (Nedd-2) processing and death of trophic factor-deprived PC12 cells and sympathetic neurons occur independently of caspase-3 (CPP32)-like activity. J Neurosci 1998; 8(22): 9204–9215.
Google Scholar
- Angelastro JM, Moon NY, Liu DX, Yang AS, Greene LA, Franke TF. Characterization of a novel isoform of caspase-9 that inhibits apoptosis. J Biol Chem 2001; 276(15): 12190–12200.
Article PubMed Google Scholar
- Stefanis L, Park DS, Friedman WJ, Greene LA. Caspase-dependent and -independent death of camptothecin-treated embryonic cortical neurons. J Neurosci 1999; 19(15): 6235–6247.
PubMed Google Scholar
- Neame SJ, Rubin LL, Philpott KL. Blocking cytochrome c activity within intact neurons inhibits apoptosis. J Cell Biol 1998; 142(6): 1583–1593.
Article PubMed Google Scholar
- Putcha GV, Deshmukh M, Johnson EM Jr. BAX translocation is a critical event in neuronal apoptosis: Regulation by neuroprotectants, BCL-2, and caspases. J Neurosci 1999; 19(17): 7476–7485.
PubMed Google Scholar
- Green D, Kroemer G. The central executioners of apoptosis: Caspases or mitochondria? Trends Cell Biol 1998; 8(7): 267–271.
Article PubMed Google Scholar
- Cory S, Adams JM. The Bcl2 family: Regulators of the cellular life-or-death switch. Nat Rev Cancer 2002; 2(9): 647–656.
Article PubMed Google Scholar
- Scorrano L, Korsmeyer SJ. Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem Biophys Res Commun 2003; 304(3): 437–444.
Article PubMed Google Scholar
- Hsu YT, Youle RJ. Nonionic detergents induce dimerization among members of the Bcl-2 family. J Biol Chem 1997; 272(21): 13829–13834.
Article PubMed Google Scholar
- Xiang H, Kinoshita Y, Knudson CM, Korsmeyer SJ, Schwartzkroin PA, Morrison RS. Bax involvement in p53-mediated neuronal cell death. J Neurosci 2003; 18(4): 1363–1373.
Google Scholar
- Kitagawa H, Tani E, Ikemoto H, Ozaki I, Nakano A, Omura S. Proteasome inhibitors induce mitochondria-independent apoptosis in human glioma cells. FEBS Lett 1999; 443(2): 181–186.
Article PubMed Google Scholar
- Li B, Dou QP. Bax degradation by the ubiquitin/proteasome-dependent pathway: Involvement in tumor survival and progression. Proc Natl Acad Sci USA 2000; 97(8): 3850–3855.
Article PubMed Google Scholar
- Dewson G, Snowden RT, Almond JB, Dyer MJ, Cohen GM. Conformational change and mitochondrial translocation of Bax accompany proteasome inhibitor-induced apoptosis of chronic lymphocytic leukemic cells. Oncogene 2003; 22(17): 2643–2654.
Article PubMed Google Scholar
- Kikuchi S, Shinpo K, Tsuji S, et al. Effect of proteasome inhibitor on cultured mesencephalic dopaminergic neurons. Brain Res 2003; 964(2): 228–236.
Article PubMed Google Scholar
- O’Connor L, Strasser A, O’Reilly LA, et al. Bim: A novel member of the Bcl-2 family that promotes apoptosis. EMBO J 1998; 17(2): 384–395.
Article PubMed Google Scholar
- Akiyama T, Bouillet P, Miyazaki T, et al. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J 2003; 22(24): 6653–6664.
Article PubMed Google Scholar
- Luciano F, Jacquel A, Colosetti P, et al. Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function. Oncogene 2003; 22(43): 6785–6793.
Article PubMed Google Scholar
- Monney L, Otter I, Olivier R, et al. Defects in the ubiquitin pathway induce caspase-independent apoptosis blocked by Bcl-2. J Biol Chem 1998; 273(11): 6121–6131.
Article PubMed Google Scholar
- Wagenknecht B, Hermisson M, Groscurth P, Liston P, Krammer PH, Weller M. Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release. J Neurochem 2000; 75(6): 2288–2297.
Article PubMed Google Scholar
- An B, Goldfarb RH, Siman R, Dou QP. Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts. Cell Death Differ 1998; 5(12): 1062–1075.
Article PubMed Google Scholar
- Herrmann JL, Briones F Jr, Brisbay S, Logothetis CJ, McDonnell TJ. Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53. Oncogene 1998; 17(22): 2889–2899.
Article PubMed Google Scholar
- Batistatou A, Merry DE, Korsmeyer SJ, Greene LA. Bcl-2 affects survival but not neuronal differentiation of PC12 cells. J Neurosci 1993; 13(10): 4422–4428.
PubMed Google Scholar
- Hou Q, Cymbalyuk E, Hsu SC, Xu M, Hsu YT. Apoptosis modulatory activities of transiently expressed Bcl-2: Roles in cytochrome C release and Bax regulation. Apoptosis 2003; 8(6): 617–629.
Article PubMed Google Scholar
- Yethon JA, Epand RF, Leber B, Epand RM, Andrews DW. Interaction with a membrane surface triggers a reversible conformational change in Bax normally associated with induction of apoptosis. J Biol Chem 2003; 278(49): 48935–48941.
Article PubMed Google Scholar
- Whitfield J, Neame SJ, Paquet L, Bernard O, Ham J. Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release. Neuron 2001; 29(3): 629–643.
Article PubMed Google Scholar
- Putcha GV, Moulder KL, Golden JP, et al. Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis. Neuron 2001; 29(3): 615–628.
Article PubMed Google Scholar
- Lang-Rollin I, Vekrellis K, Wang Q, Rideout HJ, Stefanis L. Application of proteasomal inhibitors to mouse sympathetic neurons activates the intrinsic apoptotic pathway. J Neurochem 2004; 90(6): 1511–1520.
Article PubMed Google Scholar
- Ganju N, Eastman A. Bcl-X(L) and calyculin A prevent translocation of Bax to mitochondria during apoptosis. Biochem Biophys Res Commun 2001; 291(5): 1258–1264.
Article Google Scholar
- Murphy KM, Ranganathan V, Farnsworth ML, Kavallaris M. Lock RB Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell Death Differ 2000; 7(1): 102–101.
Article PubMed Google Scholar
- Van Laethem A, Van Kelst S, Lippens S, et al. Activation of p38 MAPK is required for Bax translocation to mitochondria, cytochrome c release and apoptosis induced by UVB irradiation in human keratinocytes. FASEB J 2004; 18(15): 1946–1948.
PubMed Google Scholar
- Ishikawa Y, Kusaka E, Enokido Y, Ikeuchi T, Hatanaka H. Regulation of Bax translocation through phosphorylation at Ser-70 of Bcl-2 by MAP kinase in NO-induced neuronal apoptosis. Mol Cell Neurosci 2003; 24(2): 451–459.
Article PubMed Google Scholar
- Saikumar P, Dong Z, Patel Y, et al. Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene 1998; 17(26): 3401–3415.
Article PubMed Google Scholar
- Mikhailov V, Mikhailova M, Pulkrabek DJ, Dong Z, Venkatachalam MA, Saikumar P. Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane. J Biol Chem 2001; 276(21): 18361–18374.
Article PubMed Google Scholar
- Rukenstein A, Rydel RE, Greene LA. Multiple agents rescue PC12 cells from serum-free cell death by translation- and transcription-independent mechanisms. J Neurosci 1991; 11(8): 2552–2563.
PubMed Google Scholar
- Jabado O, Wang Q, Rideout HJ, et al. RAIDD aggregation facilitates apoptotic death of PC12 cells and sympathetic neurons. Cell Death Differ 2004; 11(6): 618–630.
PubMed Google Scholar